glp-1 news updates november 2025 Shortage = Over GLP-1 Pipeline Update: August 2025 – glp-1 news updates november 2025

MBX 4291, dual GLP-1/GIP co-agonist prodrug designed for potential once-monthly dosing and improved tolerability in obesity Recent Highlights: In June 2026, MBX Biosciences announced data that demonstrated sustained benefit of its once-weekly Canvuparatide as a potential PTH replacement therapy in chronic hypoparathyroidism

With a 100% money back guarantee, you can try the product to ensure you see the benefits

If your sore throat is from an infection, replace your toothbrush once youre no longer contagious to avoid reinfection

doi: 10.1242/dev.120.5.1243 44 DuanTDuYXingCWangHYWangRF

If you are already familiar with those peptides, the math is identical

Am J Physiol - Regul Integr Comp Physiol (2013) 305(11):R121567